Similar articles for PMID: 16835376

Year	Number of Results
1991	1
1993	1
1994	1
1996	2
1997	2
1998	7
1999	2
2000	5
2001	5
2002	8
2003	7
2004	9
2005	5
2006	7
2007	3
2008	5
2009	6
2010	3
2011	2
2012	2
2013	4
2014	5
2015	1
2016	3
2017	3
2018	2
2019	2
2020	2
2021	5
2024	0

1

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

Savoldo B, Goss JA, Hammer MM, Zhang L, Lopez T, Gee AP, Lin YF, Quiros-Tejeira RE, Reinke P, Schubert S, Gottschalk S, Finegold MJ, Brenner MK, Rooney CM, Heslop HE. Savoldo B, et al. Blood. 2006 Nov 1;108(9):2942-9. doi: 10.1182/blood-2006-05-021782. Epub 2006 Jul 11. Blood. 2006. PMID: 16835376 Free PMC article.

2

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients.

Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Transplantation. 2001 Sep 27;72(6):1078-86. doi: 10.1097/00007890-200109270-00017. Transplantation. 2001. PMID: 11579304

3

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.

Comoli P, Labirio M, Basso S, Baldanti F, Grossi P, Furione M, Viganò M, Fiocchi R, Rossi G, Ginevri F, Gridelli B, Moretta A, Montagna D, Locatelli F, Gerna G, Maccario R. Comoli P, et al. Blood. 2002 Apr 1;99(7):2592-8. doi: 10.1182/blood.v99.7.2592. Blood. 2002. PMID: 11895798 Free article.

4

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

Khanna R, Bell S, Sherritt M, Galbraith A, Burrows SR, Rafter L, Clarke B, Slaughter R, Falk MC, Douglass J, Williams T, Elliott SL, Moss DJ. Khanna R, et al. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10391-6. doi: 10.1073/pnas.96.18.10391. Proc Natl Acad Sci U S A. 1999. PMID: 10468618 Free PMC article.

5

Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients.

Sato T, Fujieda M, Maeda A, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Hattori M, Wakiguchi H. Sato T, et al. Clin Nephrol. 2008 Nov;70(5):393-403. doi: 10.5414/cnp70393. Clin Nephrol. 2008. PMID: 19000539

6

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S. Comoli P, et al. J Clin Oncol. 2005 Dec 10;23(35):8942-9. doi: 10.1200/JCO.2005.02.6195. Epub 2005 Oct 3. J Clin Oncol. 2005. PMID: 16204009 Free article. Clinical Trial.

7

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

8

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, Khanna R, Moss DJ. Sherritt MA, et al. Transplantation. 2003 May 15;75(9):1556-60. doi: 10.1097/01.TP.0000058745.02123.6F. Transplantation. 2003. PMID: 12792514

9

EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review.

Liu JY, Zhang JM, Zhan HS, Sun LY, Wei L. Liu JY, et al. Transpl Int. 2021 Dec;34(12):2483-2493. doi: 10.1111/tri.14107. Epub 2021 Oct 28. Transpl Int. 2021. PMID: 34510581 Free article. Review.

10

Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.

Kim N, Sohn HJ, Oh JH, Jeon YW, Lee HJ, Cho HI, Chung BH, Yang CW, Kim TG, Cho SG. Kim N, et al. Int J Hematol. 2018 May;107(5):596-603. doi: 10.1007/s12185-017-2381-3. Epub 2017 Nov 29. Int J Hematol. 2018. PMID: 29188583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year